FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1506577935> ?p ?o ?g. }

• W1506577935 endingPage "252" @default.
• W1506577935 startingPage "245" @default.
• W1506577935 abstract "This study hypothesized that elevated galectin-3 (Gal-3) levels would identify patients with more advanced heart failure (HF) with preserved ejection fraction (HFpEF) as assessed by key pathophysiological domains.Gal-3 is implicated in the pathogenesis of cardiac fibrosis but is also increased with normal aging and renal dysfunction. Cardiac fibrosis may contribute to cardiac dysfunction, exercise intolerance, and congestion in HFpEF.Two hundred eight patients from the RELAX (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure) trial of sildenafil in HFpEF had Gal-3 measured at enrollment. Pathophysiological domains assessed included biomarkers of neurohumoral activation, fibrosis, inflammation and myocardial necrosis, congestion severity and quality of life, cardiac structure and function, and exercise performance. Analysis adjusted for age, sex, and/or cystatin-C levels. Potential interaction between baseline Gal-3 and treatment (sildenafil) effect on the RELAX study primary endpoint (change in peak oxygen consumption) was tested.Gal-3 levels were associated with age and severity of renal dysfunction. Adjusting for age, sex, and/or cystatin-C, Gal-3 was not associated with biomarkers of neurohumoral activation, fibrosis, inflammation or myocardial necrosis, congestion or quality-of-life impairment, cardiac remodeling or dysfunction, or exercise intolerance. Gal-3 did not identify patients who responded to phosphodiesterase type 5 (PDE-5) inhibitors (interaction p = 0.53).In overt HFpEF, Gal-3 was related to severity of renal dysfunction and accounting for this, was not independently associated with severity of pathophysiological derangements or response PDE-5 inhibition. These findings underscore the need to adjust for renal function when interpreting Gal-3 levels, and call into question the value of Gal-3 to quantify disease severity in overt HFpEF." @default.
• W1506577935 created "2016-06-24" @default.
• W1506577935 creator A5022076272 @default.
• W1506577935 creator A5028644714 @default.
• W1506577935 creator A5030461468 @default.
• W1506577935 creator A5042926181 @default.
• W1506577935 creator A5048908501 @default.
• W1506577935 creator A5049537975 @default.
• W1506577935 creator A5068501665 @default.
• W1506577935 creator A5084467800 @default.
• W1506577935 creator A5090276754 @default.
• W1506577935 creator A5090322167 @default.
• W1506577935 date "2015-03-01" @default.
• W1506577935 modified "2023-10-17" @default.
• W1506577935 title "Galectin-3 in Heart Failure With Preserved Ejection Fraction" @default.
• W1506577935 cites W164205712 @default.
• W1506577935 cites W1945958562 @default.
• W1506577935 cites W1969343364 @default.
• W1506577935 cites W2000471432 @default.
• W1506577935 cites W2003056396 @default.
• W1506577935 cites W2005765093 @default.
• W1506577935 cites W2006077331 @default.
• W1506577935 cites W2014097940 @default.
• W1506577935 cites W2014189665 @default.
• W1506577935 cites W2015404118 @default.
• W1506577935 cites W2020332328 @default.
• W1506577935 cites W2043586033 @default.
• W1506577935 cites W2046774168 @default.
• W1506577935 cites W2048178709 @default.
• W1506577935 cites W2050227484 @default.
• W1506577935 cites W2050865773 @default.
• W1506577935 cites W2061150769 @default.
• W1506577935 cites W2074958057 @default.
• W1506577935 cites W2101099004 @default.
• W1506577935 cites W2119832262 @default.
• W1506577935 cites W2123248199 @default.
• W1506577935 cites W2135164569 @default.
• W1506577935 cites W2135350140 @default.
• W1506577935 cites W2137784332 @default.
• W1506577935 cites W2139571734 @default.
• W1506577935 cites W2142280282 @default.
• W1506577935 cites W2143492218 @default.
• W1506577935 cites W2143795945 @default.
• W1506577935 cites W2161106084 @default.
• W1506577935 cites W2161321429 @default.
• W1506577935 cites W2163147093 @default.
• W1506577935 cites W2166504467 @default.
• W1506577935 cites W2166805849 @default.
• W1506577935 cites W2546778110 @default.
• W1506577935 doi "https://doi.org/10.1016/j.jchf.2014.10.009" @default.
• W1506577935 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4369675" @default.
• W1506577935 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25742762" @default.
• W1506577935 hasPublicationYear "2015" @default.
• W1506577935 type Work @default.
• W1506577935 sameAs 1506577935 @default.
• W1506577935 citedByCount "48" @default.
• W1506577935 countsByYear W15065779352015 @default.
• W1506577935 countsByYear W15065779352016 @default.
• W1506577935 countsByYear W15065779352017 @default.
• W1506577935 countsByYear W15065779352018 @default.
• W1506577935 countsByYear W15065779352019 @default.
• W1506577935 countsByYear W15065779352020 @default.
• W1506577935 countsByYear W15065779352021 @default.
• W1506577935 countsByYear W15065779352022 @default.
• W1506577935 countsByYear W15065779352023 @default.
• W1506577935 crossrefType "journal-article" @default.
• W1506577935 hasAuthorship W1506577935A5022076272 @default.
• W1506577935 hasAuthorship W1506577935A5028644714 @default.
• W1506577935 hasAuthorship W1506577935A5030461468 @default.
• W1506577935 hasAuthorship W1506577935A5042926181 @default.
• W1506577935 hasAuthorship W1506577935A5048908501 @default.
• W1506577935 hasAuthorship W1506577935A5049537975 @default.
• W1506577935 hasAuthorship W1506577935A5068501665 @default.
• W1506577935 hasAuthorship W1506577935A5084467800 @default.
• W1506577935 hasAuthorship W1506577935A5090276754 @default.
• W1506577935 hasAuthorship W1506577935A5090322167 @default.
• W1506577935 hasBestOaLocation W15065779351 @default.
• W1506577935 hasConcept C126322002 @default.
• W1506577935 hasConcept C134018914 @default.
• W1506577935 hasConcept C159641895 @default.
• W1506577935 hasConcept C164705383 @default.
• W1506577935 hasConcept C2777099384 @default.
• W1506577935 hasConcept C2777321227 @default.
• W1506577935 hasConcept C2778198053 @default.
• W1506577935 hasConcept C2779548226 @default.
• W1506577935 hasConcept C2780559512 @default.
• W1506577935 hasConcept C71924100 @default.
• W1506577935 hasConcept C78085059 @default.
• W1506577935 hasConceptScore W1506577935C126322002 @default.
• W1506577935 hasConceptScore W1506577935C134018914 @default.
• W1506577935 hasConceptScore W1506577935C159641895 @default.
• W1506577935 hasConceptScore W1506577935C164705383 @default.
• W1506577935 hasConceptScore W1506577935C2777099384 @default.
• W1506577935 hasConceptScore W1506577935C2777321227 @default.
• W1506577935 hasConceptScore W1506577935C2778198053 @default.
• W1506577935 hasConceptScore W1506577935C2779548226 @default.
• W1506577935 hasConceptScore W1506577935C2780559512 @default.
• W1506577935 hasConceptScore W1506577935C71924100 @default.

• next